RELATING TO SAFE DRINKING WATER.
SB682 would amend Hawaii law to prohibit any state or county law, rule, ordinance, or regulation from requiring the addition of substances, products, or chemicals to a public water system for preventative health care or medical purposes, so long as those additives are unrelated to chemicals needed to protect drinking water from contamination. The bill is framed as aligning state law with the federal Safe Drinking Water Act and protecting informed consent, while also citing concerns about vulnerable populations and long-term exposure to added chemicals.
The bill also creates a contingency framework in case federal law is changed to allow drinking water systems to dispense chemicals or medication for bodily functions. In that event, it would require an independent environmental assessment and impose quality-control and safety conditions, including pharmaceutical-grade standards, FDA safety and effectiveness testing, limits on contaminants, and restrictions on corrosion and heavy-metal leaching. It also includes a severability clause and would take effect upon approval.
If enacted, SB682 would add a new section to chapter 340E, Hawaii Revised Statutes, limiting the authority of state and county governments to mandate chemical or medicinal additives in public drinking water for preventive or medical purposes. It would not affect additives used for conventional water treatment and contamination control, but it would bar any requirement to use water systems as a vehicle for health-related treatment unless federal law is changed and the bill’s additional safeguards are satisfied. The measure would primarily affect the Department of Health, county governments, public water systems, and any future state implementation of a federal rule permitting medication delivery through drinking water.
The bill’s text reflects strong support for water purity, informed consent, and precautionary regulation, and its framing suggests a skeptical view of adding non-treatment chemicals to drinking water. No committee transcript or vote record is available in the provided materials, so there is no documented floor or committee debate to gauge broader legislative sentiment. The available status information shows the bill was re-referred to HHS and JDC on January 31, 2025, indicating continued committee consideration rather than final disposition.
The central point of contention is whether state or local governments should be able to require additives in public water systems for preventive health or medical purposes. Supporters of the bill’s approach would likely emphasize informed consent, environmental protection, and potential risks to sensitive populations, while opponents may view the measure as unnecessary, speculative, or aimed at a policy scenario not currently authorized under federal law. The bill also raises potential debate over its detailed contingency requirements, including FDA testing, environmental assessment obligations, and liability guarantees, which could be seen as either prudent safeguards or burdensome conditions.